Identification of novel DNA methylation inhibitors via a two-component reporter gene system

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Lin, Yi Shiuan ^a   Shaw, Arthur Y ^b   Wang, Shi Gang ^a   Hsu, Chia Chen ^a   Teng, I Wen ^a   Tseng, Min Jen ^a   Huang, Tim Hm ^c   Chen, Ching Shih ^c   Leu, Yu Wei ^a   Hsiao, Shu Huei ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF ARIZONA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 E; 4 O; 5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CI 41; CI 51; DNA METHYLTRANSFERASE INHIBITOR; ENHANCED GREEN FLUORESCENT PROTEIN; GLUTATHIONE TRANSFERASE P1; IM 25; IM 9; PROCAINAMIDE; UNCLASSIFIED DRUG; ANTIARRHYTHMIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DRUG DERIVATIVE;

ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DNA LIBRARY; DNA METHYLATION; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TREATMENT RESPONSE; WESTERN BLOTTING; DRUG EFFECT; DRUG SCREENING; METABOLISM; TUMOR CELL LINE;

ANTI-ARRHYTHMIA AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; DNA METHYLATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MYELODYSPLASTIC SYNDROMES; PROCAINAMIDE;

EID: 78650972028     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-3     Document Type: Article

References (30)

1. Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis. C Balch KP Nephew TH Huang SA Bapat, Bioessays 2007 29 9 842 5
2. The epigenetic progenitor origin of human cancer. AP Feinberg R Ohlsson S Henikoff, Nat Rev Genet 2006 7 1 21 33
3. The genetics and epigenetics of autoimmune diseases. A Hewagama B Richardson, J Autoimmun 2009 33 1 3 11
4. Excavating relics of DNA methylation changes during the development of neoplasia. SH Hsiao TH Huang YW Leu, Semin Cancer Biol 2009 19 3 198 208
5. DNA methylation impacts on learning and memory in aging. L Liu T van Groen I Kadish TO Tollefsbol, Neurobiol Aging 2009 30 4 549 60
6. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. JE Ohm KM McGarvey X Yu L Cheng KE Schuebel L Cope HP Mohammad W Chen VC Daniel W Yu DM Berman T Jenuwein K Pruitt SJ Sharkis DN Watkins JG Herman SB Baylin, Nat Genet 2007 39 2 237 42
7. Primer: epigenetics of autoimmunity. B Richardson, Nat Clin Pract Rheumatol 2007 3 9 521 7
8. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine. JC Chuang CB Yoo JM Kwan TW Li G Liang AS Yang PA Jones, Mol Cancer Ther 2005 4 10 1515 20
9. Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. A Villar-Garea MF Fraga J Espada M Esteller, Cancer Res 2003 63 16 4984 9
10. Epigenetic therapy of cancer: past, present and future. PA Yoo PA Jones, Nat Rev Drug Discov 2006 5 1 37 50
11. Procainamide is a specific inhibitor of DNA methyltransferase 1. BH Lee S Yegnasubramanian X Lin WG Nelson, J Biol Chem 2005 280 49 40749 56
12. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. X Lin K Asgari MJ Putzi WR Gage X Yu BS Cornblatt A Kumar S Piantadosi TL DeWeese AM De Marzo WG Nelson, Cancer Res 2001 61 24 8611 6
13. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. Q Lu A Wu BC Richardson, J Immunol 2005 174 10 6212 9
14. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. B Segura-Pacheco C Trejo-Becerril E Perez-Cardenas L Taja-Chayeb I Mariscal A Chavez C Acũa AM Salazar M Lizano A Duẽas-Gonzalez, Clin Cancer Res 2003 9 5 1596 603
15. Testing of metoclopramide and procainamide for their ability to induce genotoxic effects in cultured mammalian cells. A Martelli GB Campart R Canonero F Mattioli G Brambilla, Toxicol Appl Pharmacol 1995 131 2 185 91
16. Evaluation of DNA-damaging, clastogenic, and promoting activities of metoclopramide and procainamide in rats. E Mereto L Robbiano M Ghia A Allavena A Martelli G Brambilla, Toxicol Appl Pharmacol 1995 131 2 192 7
17. DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination. SH Hsiao KD Lee CC Hsu MJ Tseng VX Jin WS Sun YC Hung KT Yeh PS Yan YY Lai HS Sun YJ Lu YS Chang SJ Tsai TH Huang YW Leu, Biochem Biophys Res Commun 2010 400 3 305 12
18. Targeted methylation of CMV and E1A viral promoters. CC Hsu HP Li YH Hung YW Leu WH Wu FS Wang KD Lee PJ Chang CS Wu YJ Lu TH Huang YS Chang SH Hsiao, Biochem Biophys Res Commun 2010 402 228 34
19. Applications of CpG island microarrays for high-throughput analysis of DNA methylation. PS Yan CM Chen H Shi F Rahmatpanah SH Wei TH Huang, J Nutr 2002 132 8 Suppl 2430S 2434S
20. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. CM Bender MM Pao PA Jones, Cancer Res 1998 58 1 95 101
21. Potentiation of MyoD1 activity by 5-aza-2′-deoxycytidine. J Chen PA JonesJ, Cell Growth Differ 1990 1 8 383 92
22. Gene structure and transcription in mouse cells with extensively demethylated DNA. LA Michalowsky PA Jones, Mol Cell Biol 1989 9 3 885 92
23. DNA methylation and drug resistance in variants of C3H10T1/2 C1 8 cells. LA Michalowsky PA Jones, Prog Clin Biol Res 1986 226 391 9
24. Altering gene expression with 5-azacytidine. PA Jones, Cell 1985 40 3 485 6
25. Effects of 5-azacytidine and its 2′-deoxyderivative on cell differentiation and DNA methylation. PA Jones, Pharmacol Ther 1985 28 1 17 27
26. Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. PA Jones SM Taylor T Mohandas LJ Shapiro, Proc Natl Acad Sci USA 1982 79 4 1215 9
27. Cellular differentiation, cytidine analogs and DNA methylation. PA Jones SM Taylor, Cell 1980 20 1 85 93
28. Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. PG Constantinides PA Jones W Gevers, Nature 1977 267 5609 364 6
29. 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination. SF Konieczny Cp Emerson Jr, Cell 1984 38 3 791 800
30. Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Y Saunthararajah CA Hillery D Lavelle R Molokie L Dorn L Bressler S Gavazova YH Chen R Hoffman J DeSimone, Blood 2003 102 12 3865 70